An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons.

Trial Profile

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 04 Dec 2012

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Herpes simplex virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Dec 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 09 Feb 2010 New source identified and integrated (University of Washington Health Sciences record no. 37304).
    • 06 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top